BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7784057)

  • 1. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
    Lukas J; Bartkova J; Welcker M; Petersen OW; Peters G; Strauss M; Bartek J
    Oncogene; 1995 Jun; 10(11):2125-34. PubMed ID: 7784057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection.
    Fan Y; Mok CK; Chan MC; Zhang Y; Nal B; Kien F; Bruzzone R; Sanyal S
    J Biol Chem; 2017 Mar; 292(12):5070-5088. PubMed ID: 28130444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels.
    Vantangoli MM; Madnick SJ; Huse SM; Weston P; Boekelheide K
    PLoS One; 2015; 10(8):e0135426. PubMed ID: 26267486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
    Li Y; Wei J; Xu C; Zhao Z; You T
    PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of trimeric proliferating cell nuclear antigen by G1-phase cyclin-dependent kinases following DNA damage with platinum-based antitumour agents.
    He G; Kuang J; Koomen J; Kobayashi R; Khokhar AR; Siddik ZH
    Br J Cancer; 2013 Oct; 109(9):2378-88. PubMed ID: 24104967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent kinetics of dentate gyrus neurogenesis in the absence of cyclin D2.
    Ansorg A; Witte OW; Urbach A
    BMC Neurosci; 2012 May; 13():46. PubMed ID: 22564330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.
    Taneja P; Maglic D; Kai F; Zhu S; Kendig RD; Fry EA; Inoue K
    Clin Med Insights Oncol; 2010 Apr; 4():15-34. PubMed ID: 20567632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.
    Kheirollahi M; Mehr-Azin M; Kamalian N; Mehdipour P
    Med Oncol; 2011 Mar; 28(1):7-14. PubMed ID: 20077038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.
    Mayr C; Bartel DP
    Cell; 2009 Aug; 138(4):673-84. PubMed ID: 19703394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.
    Susaki E; Nakayama K; Nakayama KI
    Mol Cell Biol; 2007 Jul; 27(13):4626-40. PubMed ID: 17452458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
    Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
    Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclins and breast cancer.
    Sutherland RL; Musgrove EA
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):95-104. PubMed ID: 15082921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle genes in a mouse mammary hyperplasia model.
    Said TK; Medina D
    J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):81-93. PubMed ID: 15082920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of mice expressing a single D-type cyclin.
    Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
    Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells.
    Lukaszewicz A; Savatier P; Cortay V; Kennedy H; Dehay C
    J Neurosci; 2002 Aug; 22(15):6610-22. PubMed ID: 12151540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of the pRB and p53 cell cycle control pathways.
    Stewart CL; Soria AM; Hamel PA
    J Neurooncol; 2001 Feb; 51(3):183-204. PubMed ID: 11407592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events.
    Beier R; Bürgin A; Kiermaier A; Fero M; Karsunky H; Saffrich R; Möröy T; Ansorge W; Roberts J; Eilers M
    EMBO J; 2000 Nov; 19(21):5813-23. PubMed ID: 11060032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclins and breast cancer.
    Musgrove EA; Hui R; Sweeney KJ; Watts CK; Sutherland RL
    J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):153-62. PubMed ID: 10887489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
    Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
    Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
    Dhar KK; Branigan K; Parkes J; Howells RE; Hand P; Musgrove C; Strange RC; Fryer AA; Redman CW; Hoban PR
    Br J Cancer; 1999 Dec; 81(7):1174-81. PubMed ID: 10584879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.